Recent Updates
Recently added Catalysts
PEN

Penumbra, Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 38th Annual Growth Conference in ...

Key Takeaway: ALAMEDA, Calif. , July 19, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the Canaccord Genuity 38th Annual Growth Conference in Boston, MA on Wednesday, August 8 , 2018. A webcast of the presentation will be

Full Press Release Details

ALAMEDA, Calif. , July 19, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the Canaccord Genuity 38th Annual Growth Conference in Boston, MA on Wednesday, August 8 , 2018.
Event: Canaccord Genuity 38th Annual Growth Conference
Date: Wednesday, August 8, 2018
Time: 10:00am ET / 7:00am PT
A webcast of the presentation will be available by visiting the investors section of the company's website at www.penumbrainc.com . The webcast will be available on the company's website for two weeks following the event.
About Penumbra Penumbra, Inc., headquartered in Alameda, California , is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets medical devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs. Penumbra sells its products to hospitals primarily through its direct sales organization in the United States , most of Europe , Canada and Australia , and through distributors in select international markets. The Penumbra P logo is a trademark of Penumbra, Inc. For more information, visit www.penumbrainc.com .
Investor Relations Penumbra, Inc. 510-995-2461 [email protected]
SOURCE Penumbra, Inc.

Related Links

21 %

Last updated: Jul 19, 2018